BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17036382)

  • 1. Management of pseudomyxoma peritonei.
    Qu ZB; Liu LX
    World J Gastroenterol; 2006 Oct; 12(38):6124-7. PubMed ID: 17036382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
    Järvinen P; Ristimäki A; Kantonen J; Lepistö A
    Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
    Deraco M; Kusamura S; Gronchi A
    Tumori; 2003; 89(4 Suppl):54-5. PubMed ID: 12903545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    Sugarbaker PH
    Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
    Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
    In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?
    Rana AKS; Agarwal N; Dutta S; Dokania MK; Goyal H
    J Gastrointest Cancer; 2019 Dec; 50(4):983-990. PubMed ID: 30140971
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
    Deraco M; Gronchi A; Mazzaferro V; Inglese MG; Pennacchioli E; Kusamura S; Rizzi M; Anselmi RA; Vaglini M
    Tumori; 2002; 88(5):370-5. PubMed ID: 12487553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomyxoma Peritonei: Case Report and Literature Review.
    García KM; Flores KM; Ruiz A; González FL; Rodríguez ÁM
    J Gastrointest Cancer; 2019 Dec; 50(4):1037-1042. PubMed ID: 30618002
    [No Abstract]   [Full Text] [Related]  

  • 13. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiology, clinical presentation, and management of pseudomyxoma peritonei.
    Moran BJ; Cecil TD
    Surg Oncol Clin N Am; 2003 Jul; 12(3):585-603. PubMed ID: 14567019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
    Brueggen C; Baird G; Meisheid A
    Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].
    Scuderi S; Costamagna D; Vaira M; Barone R; De Simone M
    Tumori; 2003; 89(4 Suppl):43-5. PubMed ID: 12903542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma Peritonei.
    Bartoška P; Antoš F; Vítek P; Marx J; Kopic J; Holečková P
    Klin Onkol; 2019; 32(5):329-332. PubMed ID: 31610663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.
    Cole KL; Choudry HA; Jones HL; Goodell PP; Bartlett DL
    J Surg Oncol; 2012 Sep; 106(4):513-6. PubMed ID: 22396067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
    Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anesthesia for peritonectomy with hyperthermic intraoperative peritoneal chemotherapy. Case report.
    Pretto G; Grando M; Chella N; Bergold RA; de Castro RA; Santiago A
    Rev Bras Anestesiol; 2010; 60(5):551-7. PubMed ID: 20863936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.